What is BPC-157? What the research shows

Identity

BPC-157 (Body Protection Compound 157) is a synthetic peptide of 15 amino-acid residues. The literature describes it as a fragment related to a gastric-juice protein and uses the term "stable gastric pentadecapeptide", reflecting the molecule's stability in the gastric environment.

What preclinical studies show

A large body of rodent work covers models of gastrointestinal, tendon, ligament, muscle, and vascular injury, describing cytoprotective effects and accelerated healing. Proposed mechanisms include modulation of the nitric-oxide system and vessel recruitment.

A notable feature of this literature is that much of it originates from a single research group; independent replication elsewhere is limited. That matters when weighing the reliability of the findings.

Human data

No randomised controlled efficacy trials of BPC-157 in humans have been published, and no regulator has approved it as a medicine. Claims of proven clinical effects do not match the current literature.

Catalogue status

BPC-157 in the Moscow Peptides catalogue is a research material for laboratory use. It is not intended for human use. Batch documentation is published after its provenance is verified.